Clinical trial
A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma
NCT02230917 is registered in ClinicalTrials.gov with Rebecca Silbermann as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma
- Lead sponsor
- Rebecca Silbermann
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- October 31, 2014
- Completion date
- June 30, 2016
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.